Nomura Holdings’s BeOne Medicines Ltd ONC Stock Holding History

Nomura Holdings’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-334,100	Closed	-$90.5M	–	2493
2021 Q4	$90.5M	Buy	+334,100	New	+$113M	0.23%	62

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nomura Holdings's ONC Position: Q2 2026 in Review

Nomura Holdings sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 30,942 shares — an estimated $9.19M sold.

Nomura Holdings first reported a position in ONC in Q4 2017 and held it in 13 quarters. The position peaked at $12.6M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Nomura Holdings reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
Nomura Holdings sold 30,942 BeOne Medicines Ltd shares in Q2 2026, an estimated $9.19M.
Nomura Holdings first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 13 quarters.
Nomura Holdings's BeOne Medicines Ltd position peaked at $12.6M in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.